Events

SEMINAR DESCRIPTION

The NIDA Data Share website was created to make CTN data available to the scientific community and the public at large. These data can be used for secondary analyses and thus serve to increase the contribution of the original studies conducted and extend findings into new areas and knowledge for the benefit of public health. This one-hour presentation will focus on an overview of the website, provide highlights of its structure and contents, and detail the technical procedures involved in utilizing the data for secondary analyses.

LEARNING OBJECTIVES

• Review the structure of the NIDA Data Share website.
• Understand the information provided, how to navigate through the website, and obtain all the relevant information.
• Demonstrate the technical procedures for using SAS or ASCII data sets for conducting secondary analyses.

TARGET AUDIENCE:

Everyone is welcome! This webinar is targeted to all research professionals responsible for the development of research trials and those interested in secondary analyses and expanding their use of CTN trial data sets.

About the Presenter

Abigail Matthews, PhD
Dr. Matthews joined The Emmes Corporation in January 2010 and provides statistical support for several projects, including the National Drug Abuse Treatment Clinical Trials Network (NDAT CTN). As a post- doctoral associate at the University of Pittsburgh, she began research in the genetics of alcohol dependence and engaged in analyses of psychological characteristics in childhood predicting future alcohol abuse and dependence. At Rockefeller University, Dr. Matthews collaborated with researchers at a major pharmaceutical company where she performed pharmacogenomic analyses to predict which subjects would respond to a particular drug and identify subjects at higher risk of side effects due to that medication. She also has experience working with registry data as a research assistant consulting with the Cancer Genetics Network.

Dikla Blumberg, PhD
Dr. Blumberg is the Project Manager for the National Drug Abuse Treatment Clinical Trials Network (NDAT CTN) Clinical Coordinating Center at The Emmes Corporation. She is a Social Psychologist with expertise in self-regulation processes and over 10 years of experience in behavioral research. Previously, Dr. Blumberg worked in a NIDAfunded Postdoctoral Traineeship in Drug Abuse Treatment and Services Research at UCSF, where she designed and implemented a series of experiments investigating self-regulation processes involved with tobacco dependence. Additionally, she worked on a Cancer Research Training Award at the National Cancer Institute’s Behavioral Research Program, where she was involved with projects designed to better understand health behaviors and their underlying processes.